WeedMD Commences the Sale of Cannabis Oil
Ryan Allway
January 23rd, 2018
News
WeedMD Inc. (TSX-V: WMD) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, is pleased to announce that it has launched the sale of medical cannabis oil to its growing registered patient base.
“Having taken the time to understand the needs of our patient base and market demand, we developed two unique brand of cannabis oil that are now for sale to our patients and to the seniors’ institutional market,” said Bruce Dawson-Scully, CEO of WeedMD. “Our suite of products now includes dried flower as well as cannabis oils called EntourageTM and AxisTM by WeedMD. We’ve also developed a unique awareness platform that, in addition to providing ease of access to our oil products, includes our proprietary education program to foster product awareness and cannabis education – all integral components of rolling out our robust medical cannabis oil strategy.”
“We’ve developed and perfected our oil products with the concept of whole plant medicine; utilizing the full spectrum of therapeutic compounds that cannabis has to offer and allowing more of the cannabinoids, terpenes, and flavonoids to be present for a wide range of health benefits,” said Dr. Luc Duchesne, Chief Scientific Officer, WeedMD. “Taking the time to develop specific dilutions and concentrations in a dose-controlled consumption manner is significant to our patient community and medical partners.”
Having secured a license from Health Canada on December 1, 2017 to sell cannabis oils, WeedMD’s product offerings include two cannabis oil platforms called EntourageTM (for patients registered under the Access to Cannabis for Medical Purposes Regulations program, “ACMPR”) and AxisTM (for the seniors’ care market):
ENTOURAGETM cannabis oil is specially formulated for our patients under the ACMPR program. Named after the Entourage Effect – a term used to describe medications that utilize the full spectrum of therapeutic compounds that cannabis has to offer, it is available in three offerings: High THC oil; Hybrid – equal concentrations of THC and CBD oil; and High CBD oil.
AXISTM is a unique line specially formulated to meet the needs of seniors, offering consistent concentrations that permit medical practitioners to easily convert dosages from synthetic cannabinoid medications. It is also available in high THC oil and a Hybrid variant – equal concentrations of THC and CBD oil.
The Company is committed to ensuring that its cannabis oils combined with its educational and product platforms meet the needs of all its markets. See video here. All oil products are now available for purchase by current medical partners and patients via WeedMD’s website here. Read more about the oil sales license here. WeedMD will continue to focus on securing further supply contracts in the seniors’ care market, offering its proprietary integrated care program along with its cannabis products. The Company’s expansion into a large-scale modern greenhouse will be the main supply source for its medical cannabis patients as well as for the future adult-use market. For more about the expansion, read here.
For more information, access our investor presentation here and corporate video here.
About WeedMD Inc.:
WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates a 26,000 sq. ft. indoor facility in Aylmer, Ontario, and is awaiting its second-site cultivation license for its greenhouse facility located in Strathroy, Ontario, representing 610,000 sq. ft. or 14 acres under glass. WeedMD has entered into supply agreements in addition to strategic relationships with established cannabis brands. The Company is focused on providing medical cannabis to the long-term care, assisted living and seniors’ markets in Canada through its specialized and comprehensive platform. It is dedicated to educating healthcare practitioners and furthering public understanding of the role that medical cannabis plays – including as it pertains to regulatory requirements, indications and potential side effects.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America. It is leveraging its 30-years as a mega-scale, low-cost greenhouse grower to capitalize on the cannabis opportunity in Canada.
Wildflower Brands is a Vancouver-based company developing and designing brands that focus on plant-based health and wellness products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
